Funders · Entity Annotation Prototype (beta)

5,089articles mentioning funders

9,137funder mentions

3,238distinct funders extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted funders

Showing 1,081–1,140 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.

Clinical Events Committee1 Clinical Trial Registry-India1 Clinical Trials Ontario Research Ethics Board1 Clinical Trials Registry1 Clinical Trials Registry NCT064716081 Clinical Trials Registry of India1 Clinical Trials Registry-India1 ClinicalTrials gov. NCT047970131 ClinicalTrials. gov1 ClinicalTrials.gov NCT045855811 ClinicalTrials.gov NCT057782141 ClinicalTrials.gov NCT059099821 ClinicalTrials.gov NCT064215321 ClinicalTrials.gov NCT070528901 ClinicalTrials.gov Registry1 ClinicalTrialsRegister.eu1 Clinicaltrials.gov NCT063024001 Clinigen Limited1 CoImpact1 CoMSA1 CoSRH1 Coalition1 Coalition for National Trauma Research1 Coca-Cola1 Cochrane Central Database1 Cochrane Central Register of Clinical Trials1 Cochrane Central Registry1 Cochrane Controlled Trials Register1 Cochrane Pregnancy and Childbirth Register1 Cochrane Rapid Review Methods Group1 Cochrane network1 Cochrane-CENTRAL1 College of Sexual and Reproductive Healthcare1 Colonial Medical Service1 Colt Foundation1 Comisión Interministerial de Precios de Medicamentos1 Comitato Etico Campania 21 Comité de Protection des Personnes Est1 Comité de Protection des Personnes Ile de France I1 Comité de Protection des Personnes Ile de France XI1 Comité de Protection des Personnes Nord-Ouest II1 Comité de Protection des Personnes Ouest V1 Comité de Protection des Personnes Ouest VI1 Comité de Protection des Personnes Sud-Est VI1 Comité de protection des personnes Est III1 Comité de protection des personnes Ile de France IV1 Comité de protection des personnes Nord Ouest I1 Comité de protection des personnes Île-de-France II1 Comité de Ética en Investigación Biomédica1 Comités de Protection des Personnes Ouest-I Ethics Committee1 Commission cantonale d’éthique de la recherche1 Committee of Hospital Universitario 12 de Octubre1 Community Interest Company1 Community Voluntary Services1 Company Chemists’ Association1 Compass Therapeutics1 Compassion in Dying1 Conexus Nuclear Inc.1 Confederación Sudamericana de Fútbol1 Confederation of Sports1

View all 3,238 funders on one page

Articles mentioning funders

5,089 articles · page 55 of 425

485 Utilization of adjuvant immunotherapy for stage IIB-IIC melanoma in US in the first year following FDA approval

jitc · abstract · 2025-11-04 · 3 matching annotations

82.3%

Medicare NCDB stage IIB/C melanoma Pembrolizumab stage IIB/IIC melanoma FDA adjuvant immunotherapy

…When limiting to post-approval among patients with IIC disease, Medicare and uninsured compared to privately insured were less likely to…

514 Biomarker insights and long-term outcomes of TILT-123 oncolytic adenovirus combined with tumor-infiltrating lymphocytes in refractory metastatic melanoma: results from the TUNINTIL phase 1 trial

jitc · abstract · 2025-11-04 · 3 matching annotations

88.1%

Danish Medicines Agency FDA Danish National Ethics Committee TILT-123 MM igrelimogene litadenorepvec metastatic melanoma lymphodepleting chemotherapy

…al was approved by the Danish National Ethics Committee and the Danish Medicines Agency with the approval number 1905760. All approvals were obtained p…

540 Phase I trial of DOC1021 cell-based immunotherapy for resectable or borderline resectable pancreatic ductal adenocarcinoma

jitc · abstract · 2025-11-04 · 3 matching annotations

90.9%

Food and Drug Administration Cancer Cures 4 Kids Diakonos Oncology Corporation DOC1021 Pancreatic ductal adenocarcinoma (PDAC)DOC1021-related peg-IFN Baylor College of Medicine WCG institutional review board

…iew board, an independent data safety monitoring board, and the Food and Drug Administration. All patients provided written, informed consent prior to enrol…

763 Charting immune and cancer metabolism co-evolution during metastasis

jitc · abstract · 2025-11-04 · 3 matching annotations

94.0%

National Natural Science Foundation of China The Strategic Priority Research Program neoadjuvant chemotherapy Fudan University Zhongshan Hospital Chinese Academy of Sciences CRLM

…nt chemotherapy.Acknowledgements This work was supported by the National Natural Science Foundation of China (no. 81961128025; to Q. Gao); National Natural Science Foundati…

905 Regulation of radiation-induced innate immune signaling in patient-derived triple-negative breast cancer organoids

jitc · abstract · 2025-11-04 · 3 matching annotations

79.8%

DOD W81XWH-21-2-0034 Burroughs Wellcome Physician-Scientist Award BCRF 24-053 pembrolizumab triple negative breast cancer TNBC#2 TNBC TNBC#1

…inations.Acknowledgements Funding: Supported by BCRF 24-053 and DOD W81XWH-21-2-0034. DS is supported by a Burroughs Wellcome Physician-Scientist Aw…

A global analysis of quarantine and isolation policies governing outbreak responses

bmjgh · abstract · 2025-11-03 · 3 matching annotations

86.5%

UN United Nations COVID-19

… jurisdictional authority and enforcement mechanisms.Results Of UN Member States, 91.67% (176/192) had legally enforceable policie…